Chang Ho Ahn
Director/Miembro de la Junta en TheraTarget, Inc. .
Cargos activos de Chang Ho Ahn
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
TheraTarget, Inc.
 TheraTarget, Inc. Pharmaceuticals: MajorHealth Technology TheraTarget, Inc. develops innovative polymer therapeutics for the treatment of cancer. It is a biopharmaceutical drug delivery company developing a variety of polymer-drug conjugates utilizing our nanopolymer drug delivery technologies. The company was founded in October 2008 and is headquartered in Salt Lake, UT. | Director/Miembro de la Junta | - | - |
Historial de carrera de Chang Ho Ahn
Antiguos cargos conocidos de Chang Ho Ahn.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| REXAHN PHARMACEUTICALS, INC. | Director/Miembro de la Junta | 22/06/2015 | 31/08/2017 |
| Presidente | 01/05/2005 | 22/06/2015 | |
| Director Técnico/Científico/I+D | 08/03/2011 | - | |
| Fundador | 19/03/2001 | 31/08/2017 | |
| Presidente | 01/05/2005 | 05/02/2013 | |
| Rexahn Corp. | Director Ejecutivo | 01/03/2001 | 01/05/2005 |
| Presidente | 01/03/2001 | 01/05/2005 | |
| The Society of Biomedical Research | Presidente | 01/01/2000 | 01/01/2003 |
| Center for Drug Evaluation & Research | Corporate Officer/Principal | 01/01/1988 | 01/01/2001 |
Formación de Chang Ho Ahn.
| The Ohio State University | Doctorate Degree |
| Creighton University | Undergraduate Degree |
| Seoul National University | Undergraduate Degree |
Estadísticas
Internacional
| Estados Unidos | 8 |
| Corea del Sur | 2 |
Operativa
| Director/Board Member | 2 |
| Chairman | 2 |
| President | 2 |
Sectorial
| Consumer Services | 4 |
| Health Technology | 3 |
| Government | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas privadas | 5 |
|---|---|
Rexahn Pharmaceuticals, Inc.
 Rexahn Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Rexahn Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in the research and development of oncology therapeutics. Its drug candidates include the following: RX-31171 for pancreatic, bladder, colon, and lung cancer; and RX-5902 for metastatic triple negative breast cancer. The company was founded by Chang Ho Ahn on March 19, 2001 and is headquartered in Rockville, MD. | Health Technology |
| The Society of Biomedical Research | |
| Center for Drug Evaluation & Research | Government |
| Rexahn Corp. | Finance |
TheraTarget, Inc.
TheraTarget, Inc. Pharmaceuticals: MajorHealth Technology TheraTarget, Inc. develops innovative polymer therapeutics for the treatment of cancer. It is a biopharmaceutical drug delivery company developing a variety of polymer-drug conjugates utilizing our nanopolymer drug delivery technologies. The company was founded in October 2008 and is headquartered in Salt Lake, UT. | Health Technology |
- Bolsa de valores
- Insiders
- Chang Ho Ahn
- Experiencia
